Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives

dc.contributor.author Evranos-Aksoz, Begüm
dc.contributor.author Baysal, İpek
dc.contributor.author Yabanoğlu-Çiftçi, Samiye
dc.contributor.author Djikic, Teodora
dc.contributor.author Yelekçi, Kemal
dc.contributor.author Uçar, Gülberk
dc.contributor.author Ertan, Rahmiye
dc.date.accessioned 2019-06-27T08:02:11Z
dc.date.available 2019-06-27T08:02:11Z
dc.date.issued 2015
dc.description.abstract A group of 35-diaryl-2-pyrazoline and hydrazone derivatives was prepared via the reaction of various chalcones with hydrazide compounds in ethanol. Twenty original compounds were synthesized. Ten of these original compounds have a pyrazoline structure nine of these original compounds have a hydrazone structure and one of these original compounds has a chalcone structure. Structural elucidation of the compounds was performed by IR H-1 NMR C-13 NMR mass spectral data and elemental analyses. These compounds were tested for their inhibitory activities toward the A and B isoforms of human monoamine oxidase (MAO). Except for 3k and 6c all compounds were found to be competitive reversible and selective inhibitors for either one of the isoforms (hMAO-A or MAO-B). Compounds 3k and 6c were found to be competitive reversible but non-selective MAO inhibitors. Compound 6h showed hMAO-B inhibitory activity whereas the others potently inhibited hMAO-A. Compound 5c showed higher selectivity than the standard drug moclobemide. According to the experimental K-i values compounds 6i 6d and 6a exhibited the highest inhibitory activity toward hMAO-A. The AutoDock 4.2 program was employed to perform automated molecular docking. The calculated results obtained computationally were in good agreement with the experimental values. en_US]
dc.identifier.doi 10.1002/ardp.201500212 en_US
dc.identifier.issn 0365-6233
dc.identifier.issn 1521-4184
dc.identifier.scopus 2-s2.0-84942987491 en_US
dc.identifier.uri https://hdl.handle.net/20.500.12469/569
dc.identifier.uri https://doi.org/10.1002/ardp.201500212
dc.language.iso en en_US
dc.publisher Wiley-VCH Verlag GmbH en_US
dc.relation.ispartof Archiv der Pharmazie
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject 2-Pyrazoline en_US
dc.subject Hydrazone en_US
dc.subject MAO inhibitors en_US
dc.subject Molecular docking en_US
dc.title Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.institutional Yelekçi, Kemal en_US
gdc.bip.impulseclass C4
gdc.bip.influenceclass C4
gdc.bip.popularityclass C4
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department Fakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Biyoinformatik ve Genetik Bölümü en_US
gdc.description.endpage 756
gdc.description.issue 10
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 743 en_US
gdc.description.volume 348 en_US
gdc.description.wosquality Q2
gdc.identifier.openalex W1638969521
gdc.identifier.pmid 26293971 en_US
gdc.identifier.wos WOS:000362565600006 en_US
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 9.0
gdc.oaire.influence 3.550158E-9
gdc.oaire.isgreen false
gdc.oaire.keywords 2-Pyrazoline
gdc.oaire.keywords Monoamine Oxidase Inhibitors
gdc.oaire.keywords Protein Conformation
gdc.oaire.keywords Moclobemide
gdc.oaire.keywords Hydrazones
gdc.oaire.keywords MAO inhibitors
gdc.oaire.keywords Hydrazone
gdc.oaire.keywords Molecular Docking Simulation
gdc.oaire.keywords Kinetics
gdc.oaire.keywords Structure-Activity Relationship
gdc.oaire.keywords Drug Design
gdc.oaire.keywords Molecular docking
gdc.oaire.keywords Humans
gdc.oaire.keywords Pyrazoles
gdc.oaire.keywords Monoamine Oxidase
gdc.oaire.popularity 7.823281E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 0303 health sciences
gdc.oaire.sciencefields 01 natural sciences
gdc.oaire.sciencefields 0104 chemical sciences
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.openalex.collaboration National
gdc.openalex.fwci 1.08430063
gdc.openalex.normalizedpercentile 0.78
gdc.opencitations.count 23
gdc.plumx.crossrefcites 20
gdc.plumx.mendeley 27
gdc.plumx.pubmedcites 2
gdc.plumx.scopuscites 27
gdc.relation.journal Archiv Der Pharmazie
gdc.scopus.citedcount 27
gdc.virtual.author Yelekçi, Kemal
gdc.wos.citedcount 21
relation.isAuthorOfPublication 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isAuthorOfPublication.latestForDiscovery 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isOrgUnitOfPublication 71ce8622-7449-4a6a-8fad-44d881416546
relation.isOrgUnitOfPublication 2457b9b3-3a3f-4c17-8674-7f874f030d96
relation.isOrgUnitOfPublication b20623fc-1264-4244-9847-a4729ca7508c
relation.isOrgUnitOfPublication.latestForDiscovery 71ce8622-7449-4a6a-8fad-44d881416546

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Synthesis and Screening of Human Monoamine Oxidase-AInhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.pdf
Size:
1.23 MB
Format:
Adobe Portable Document Format
Description: